Viewing Study NCT05634733



Ignite Creation Date: 2024-05-06 @ 6:21 PM
Last Modification Date: 2024-10-26 @ 2:46 PM
Study NCT ID: NCT05634733
Status: RECRUITING
Last Update Posted: 2024-04-10
First Post: 2022-11-22

Brief Title: Change in MAPSE During Treatment of Sepsis
Sponsor: University of Maryland Baltimore
Organization: University of Maryland Baltimore

Study Overview

Official Title: Evaluation of Mitral Annulus Systolic Plane Excursion MAPSE in Emergency Department Patients With Sepsis
Status: RECRUITING
Status Verified Date: 2024-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Patients with bloodstream infections sepsis have been found in prior studies to have infection-related heart dysfunction even if they did not have preexisting heart problems Factors related to the infection may cause the heart to not pump as well as it should causing critical illness in the form of low blood pressure shock and heart failure Ultrasound is frequently used in the emergency department to evaluate why a patient might have low blood pressure Part of that evaluation may include obtaining ultrasound images and making measurements about how well or poorly the heart is pumping The investigators will evaluate a certain measurement that relates to cardiac function determine how it changes in patients before and after they are treated for septic shock This will involve placing an ultrasound probe on the patients chest measuring the upward and downward movement of the mitral valve the mitral annulus systolic plane excursion MAPSE and comparing the measurements before and after treatment is started The investigators are attempting to determine if this measurement improves before and after treatment
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None